{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:16:14Z","timestamp":1777594574232,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T00:00:00Z","timestamp":1646870400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012581","name":"The Macula Foundation Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012581","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1188694"],"award-info":[{"award-number":["GNT1188694"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1054712"],"award-info":[{"award-number":["GNT1054712"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["MRF1142962"],"award-info":[{"award-number":["MRF1142962"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1116360"],"award-info":[{"award-number":["GNT1116360"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014834","name":"The McCusker Charitable Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014834","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.exer.2022.109024","type":"journal-article","created":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T19:44:20Z","timestamp":1646682260000},"page":"109024","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Anti-retinal IgG antibodies in patients with early and advanced type 2 macular telangiectasia"],"prefix":"10.1016","volume":"218","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5732-7387","authenticated-orcid":false,"given":"Samuel","family":"McLenachan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandrakumar","family":"Balaratnasingam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9078-7059","authenticated-orcid":false,"given":"Rachael C.","family":"Heath Jeffery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shang-Chih","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoffrey","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Dolz-Marco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7477-2263","authenticated-orcid":false,"given":"Tommaso","family":"Bacci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johnny","family":"Lo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1077-8321","authenticated-orcid":false,"given":"Steven","family":"Wiffen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence A.","family":"Yannuzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2809-9930","authenticated-orcid":false,"given":"Fred K.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2022.109024_bib1","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.autrev.2009.01.002","article-title":"Autoantibody targets and their cancer relationship in the pathogenicity of paraneoplastic retinopathy","volume":"8","author":"Adamus","year":"2009","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.exer.2022.109024_bib2","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1167\/iovs.14-15739","article-title":"Latest updates on antiretinal autoantibodies associated with vision loss and breast cancer","volume":"56","author":"Adamus","year":"2015","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2022.109024_bib3","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/1471-2415-14-154","article-title":"Prevalence of anti-retinal autoantibodies in different stages of Age-related macular degeneration","volume":"14","author":"Adamus","year":"2014","journal-title":"BMC Ophthalmol."},{"key":"10.1016\/j.exer.2022.109024_bib4","first-page":"2323","article-title":"Systemic immunotherapy delays photoreceptor cell loss and prevents vascular pathology in Royal College of Surgeons rats","volume":"18","author":"Adamus","year":"2012","journal-title":"Mol. Vis."},{"key":"10.1016\/j.exer.2022.109024_bib5","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1002\/pmic.200500457","article-title":"Identification of an anti-aldolase autoantibody as a diagnostic marker for diabetic retinopathy by immunoproteomic analysis","volume":"6","author":"Ahn","year":"2006","journal-title":"Proteomics"},{"key":"10.1016\/j.exer.2022.109024_bib6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/bjo.69.1.19","article-title":"Autoimmunity in hereditary retinal degeneration. I. Basic studies","volume":"69","author":"Chant","year":"1985","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.exer.2022.109024_bib7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.preteyeres.2012.11.002","article-title":"Macular telangiectasia type 2","volume":"34","author":"Charbel Issa","year":"2013","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.exer.2022.109024_bib8","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s10633-017-9587-9","article-title":"Acute progressive paravascular placoid neuroretinopathy with negative-type electroretinography in paraneoplastic retinopathy","volume":"134","author":"Chen","year":"2017","journal-title":"Documenta ophthalmologica. Adv. Ophthalmol."},{"key":"10.1016\/j.exer.2022.109024_bib9","first-page":"113","article-title":"An immunologic study on age-related macular degeneration","volume":"9","author":"Chen","year":"1993","journal-title":"Yan ke xue bao = Eye Sci."},{"key":"10.1016\/j.exer.2022.109024_bib10","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/j.1442-9071.2006.01281.x","article-title":"Retinal autoantibody profile in early age-related macular degeneration: preliminary findings from the Blue Mountains Eye Study","volume":"34","author":"Cherepanoff","year":"2006","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.exer.2022.109024_bib11","first-page":"1335","article-title":"A New Classification for Macular Telangiectasia type 2 based on multi-modal imaging","volume":"60","author":"Chew","year":"2019","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2022.109024_bib12","first-page":"491","article-title":"Nature and functions of autoantibodies. Nature clinical practice","volume":"4","author":"Elkon","year":"2008","journal-title":"Rheumatology"},{"key":"10.1016\/j.exer.2022.109024_bib13","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.cophys.2018.03.010","article-title":"The evolution of greater humoral immunity in females than males: implications for vaccine efficacy","volume":"6","author":"Fink","year":"2018","journal-title":"Curr. Opin. Physiol."},{"key":"10.1016\/j.exer.2022.109024_bib14","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1001\/archopht.1986.01050160101022","article-title":"Blood-retinal barrier function in patients with cone or cone-rod dystrophy","volume":"104","author":"Fishman","year":"1986","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2022.109024_bib15","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1056\/NEJMoa1815111","article-title":"Serine and lipid metabolism in macular disease and peripheral neuropathy","volume":"381","author":"Gantner","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.exer.2022.109024_bib16","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1001\/archopht.118.11.1525","article-title":"Autoimmune retinopathy: patients with antirecoverin immunoreactivity and panretinal degeneration","volume":"118","author":"Heckenlively","year":"2000","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2022.109024_bib17","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0002-9394(98)00446-2","article-title":"Association of antiretinal antibodies and cystoid macular edema in patients with retinitis pigmentosa","volume":"127","author":"Heckenlively","year":"1999","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2022.109024_bib18","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1136\/bjo.69.10.758","article-title":"Autoimmunity in hereditary retinal degenerations. II. Clinical studies: antiretinal antibodies and fluorescein angiogram findings","volume":"69","author":"Heckenlively","year":"1985","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.exer.2022.109024_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145323","article-title":"Circulating autoantibodies in age-related macular degeneration recognize human macular tissue antigens implicated in autophagy, immunomodulation, and protection from oxidative stress and apoptosis","volume":"10","author":"Iannaccone","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.exer.2022.109024_bib20","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/978-3-030-27378-1_29","article-title":"Increased protein citrullination as a trigger for resident immune system Activation, intraretinal inflammation, and promotion of anti-retinal autoimmunity: intersecting paths in retinal degenerations of potential therapeutic relevance","volume":"1185","author":"Iannaccone","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.exer.2022.109024_bib21","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nri.2016.90","article-title":"Sex differences in immune responses","volume":"16","author":"Klein","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.exer.2022.109024_bib22","doi-asserted-by":"crossref","first-page":"e610","DOI":"10.1111\/aos.12435","article-title":"Circulating anti-retinal antibodies in response to anti-angiogenic therapy in exudative age-related macular degeneration","volume":"92","author":"Kubicka-Trz\u0105ska","year":"2014","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.exer.2022.109024_bib23","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jneuroim.2012.10.007","article-title":"Autoimmune responses against photoreceptor antigens during retinal degeneration and their role in macrophage recruitment into retinas of RCS rats","volume":"254","author":"Kyger","year":"2013","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.exer.2022.109024_bib24","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.yexmp.2012.03.007","article-title":"Identification of anti-retinal antibodies in patients with age-related macular degeneration","volume":"93","author":"Morohoshi","year":"2012","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.exer.2022.109024_bib25","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1365-2567.2005.02173.x","article-title":"Circulating anti-retinal antibodies as immune markers in age-related macular degeneration","volume":"115","author":"Patel","year":"2005","journal-title":"Immunology"},{"key":"10.1016\/j.exer.2022.109024_bib26","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1016\/j.ophtha.2010.04.001","article-title":"Perifoveal m\u00fcller cell depletion in a case of macular telangiectasia type 2","volume":"117","author":"Powner","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2022.109024_bib27","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0165-5728(01)00374-5","article-title":"Blood-retinal barrier breakdown in experimental coronavirus retinopathy: association with viral antigen, inflammation, and VEGF in sensitive and resistant strains","volume":"119","author":"Vinores","year":"2001","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.exer.2022.109024_bib28","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1038\/s41467-018-04408-0","article-title":"Testosterone is an endogenous regulator of BAFF and splenic B cell number","volume":"9","author":"Wilhelmson","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.exer.2022.109024_bib29","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.1167\/iovs.13-12050","article-title":"Anti-retinal antibodies in patients with macular telangiectasia type 2","volume":"54","author":"Zhu","year":"2013","journal-title":"Investig. Ophthalmol. Vis. Sci."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483522001051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483522001051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T20:33:19Z","timestamp":1777408399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483522001051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":29,"alternative-id":["S0014483522001051"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2022.109024","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-retinal IgG antibodies in patients with early and advanced type 2 macular telangiectasia","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2022.109024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109024"}}